Numis Securities Ltd reaffirmed their add rating on shares of Udg Healthcare PLC (LON:UDG) in a research report sent to investors on Thursday morning. Numis Securities Ltd currently has a GBX 730 ($9.12) price target on the stock.

Several other research analysts have also recently weighed in on the stock. N+1 Singer restated a buy rating and set a GBX 746 ($9.32) price target on shares of Udg Healthcare PLC in a report on Thursday. Goodbody restated a buy rating on shares of Udg Healthcare PLC in a report on Thursday. Berenberg Bank boosted their price target on shares of Udg Healthcare PLC from GBX 700 ($8.75) to GBX 720 ($9.00) and gave the stock a buy rating in a report on Friday, November 18th. Liberum Capital assumed coverage on shares of Udg Healthcare PLC in a report on Thursday, October 27th. They set a buy rating and a GBX 750 ($9.37) price target on the stock. Finally, Davy Research restated an outperform rating on shares of Udg Healthcare PLC in a report on Monday, October 24th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock has a consensus rating of Buy and a consensus price target of GBX 714.33 ($8.92).

Udg Healthcare PLC (LON:UDG) opened at 637.00 on Thursday. The company’s market capitalization is GBX 1.57 billion. The stock’s 50 day moving average is GBX 653.03 and its 200 day moving average is GBX 615.15. Udg Healthcare PLC has a one year low of GBX 491.30 and a one year high of GBX 692.50.

In related news, insider Chris Corbin sold 90,849 shares of the company’s stock in a transaction that occurred on Monday, September 26th. The shares were sold at an average price of GBX 634 ($7.92), for a total transaction of £575,982.66 ($719,618.52).

WARNING: This piece was first published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another domain, it was stolen and republished in violation of international copyright laws. The legal version of this piece can be read at

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.

Receive News & Stock Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related stocks with our FREE daily email newsletter.